Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT04592484 |
| Title | A First-in-Human Study of CDK-002 (exoSTING) in Subjects With Advanced/Metastatic, Recurrent, Injectable Solid Tumors |
| Recruitment | Completed |
| Gender | both |
| Phase | Phase Ib/II |
| Variant Requirements | No |
| Sponsors | Codiak BioSciences |
| Indications | |
| Therapies | |
| Age Groups: | senior | adult |
| Covered Countries | USA | GBR |
| Facility | Status | City | State | Zip | Country | Details |
|---|---|---|---|---|---|---|
| Honor Health | Scottsdale | Arizona | 85258 | United States | Details | |
| Columbia University/CUMC | New York | New York | 10032 | United States | Details | |
| University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
| NEXT Oncology | San Antonio | Texas | 78229 | United States | Details | |
| The Beatson West of Scotland Cancer Centre/ Gartnavel General Hospital | Glasgow | G12 0YN | United Kingdom | Details | ||
| Oxford University Hospitals NHS Trust | Headington | OX3 9DU | United Kingdom | Details | ||
| The Royal Marsden Hospital | London | SW3 6JJ | United Kingdom | Details | ||
| The Christie NHS Foundation Trust | Manchester | M20 4BX | United Kingdom | Details |